Abbott Next-Generation Arterial Hemostatis Device To Retail For $225
This article was originally published in The Gray Sheet
Executive Summary
Abbott's most recent entry into the vascular closure market, the Closer, developed and being manufactured by the company's recently acquired Perclose subsidiary, will sell for $225, the firm announced following launch of the product on Nov. 30.